As its establishment in early 2000, the Northern Ireland Cancer Trials Centre has significantly enhanced participation in cancer clinical trials in Northern Ireland, such that in the period between April 2013 and March 2014, a total of 1665 patients in Northern Ireland were recruited to cancer clinical trials and related translational studies, a rate that is nearly twice the recruitment target of 850 patients (10% of the incident cancers in NI)

As its establishment in early 2000, the Northern Ireland Cancer Trials Centre has significantly enhanced participation in cancer clinical trials in Northern Ireland, such that in the period between April 2013 and March 2014, a total of 1665 patients in

Comparison of stable condition surface-associated matriptase while dependant on biotinylation with S-NHS-SS-biotin towards the accumulated biotin-RQRR-CMK labeled matriptase more than a 30 min period or much longer demonstrates only a small fraction of surface-associated matriptase on Caco-2 cells can bind biotin-RQRR-CMK (shape 2A, compare street 1 to lanes 4C6)

Comparison of stable condition surface-associated matriptase while dependant on biotinylation with S-NHS-SS-biotin towards the accumulated biotin-RQRR-CMK labeled matriptase more than a 30 min period or much longer demonstrates only a small fraction of surface-associated matriptase on Caco-2 cells can bind